Mammalian innate resistance to highly pathogenic avian influenza H5N1 virus infection is mediated through reduced proinflammation and infectious virus release

Journal of Virology

Volumn 86, Issue 17, 2012, Pages 9201-9210

  Nelli, Rahul K ^a   Dunham, Stephen P ^a   Kuchipudi, Suresh V ^a   White, Gavin A ^a   Baquero Perez, Belinda ^a   Chang, Pengxiang ^a   Ghaemmaghami, Amir ^b   Brookes, Sharon M ^c   Brown, Ian H ^c   Chang, Kin Chow ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 6; JANUS KINASE; STAT PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; HOST RESISTANCE; HUMAN; HUMAN CELL; INFECTION RESISTANCE; INFECTION SENSITIVITY; INFLAMMATION; INFLUENZA A (H5N1); INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H5N1; INNATE IMMUNITY; LUNG ALVEOLUS EPITHELIUM; MACROPHAGE; MAMMAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPECIES COMPARISON; SWINE; TRANSCRIPTION REGULATION; VIRUS RELEASE; VIRUS SHEDDING;

ANIMALS; CELL LINE; CELLS, CULTURED; CHEMOKINES; CHICK EMBRYO; CYTOKINES; HUMANS; IMMUNITY, INNATE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; MACROPHAGES; ORTHOMYXOVIRIDAE INFECTIONS; SWINE; SWINE DISEASES; VIRUS RELEASE;

AVES; INFLUENZA A VIRUS; MAMMALIA; SUIDAE;

EID: 84866175098     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00244-12     Document Type: Article

References (46)

1. Baskin CR, et al. 2009. Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc. Natl. Acad. Sci. U. S. A. 106:3455-3460.
2. Cacalano NA, Sanden D, Johnston JA. 2001. Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras. Nat. Cell Biol. 3:460-465.
3. Cameron CM, et al. 2008. Gene expression analysis of host innate immune responses during lethal H5N1 infection in ferrets. J. Virol. 82: 11308-11317.
4. Chan MCW, et al. 2005. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir. Res. 6:135.
5. Chen LM, et al. 2012. In vitro evolution of H5N1 avian influenza virus toward human-type receptor specificity. Virology 422:105-113.
6. Choi YK, et al. 2005. Studies of H5N1 influenza virus infection of pigs by using viruses isolated in Vietnam and Thailand in 2004. J. Virol. 79:10821-10825.
7. Cohney SJ, et al. 1999. SOCS-3 is tyrosine phosphorylated in response to interleukin-2 and suppresses STAT5 phosphorylation and lymphocyte proliferation. Mol. Cell. Biol. 19:4980-4988.
8. Cyranski D. 2005. Bird flu spreads among Java's pigs. Nature 435:390-391.
9. Hartshorn KL, White MR, Tecle T, Holmskov U, Crouch EC. 2006. Innate defence against human neutrophil defensins and interactions of defensins with surfactant protein D. J. Immunol. 176:6962-6972.
10. Hui KPY, et al. 2009. Induction of proinflammatory cytokines in primary human macrophages by influenza A virus (H5N1) is selectively regulated by IFN regulatory factor 3 and p38 MAPK. J. Immunol. 182:1088-1098.
11. Ilyushina NA, Seiler JP, Rehg JE, Webster RG, Govorkova EA. 2010. Effect of neuraminidase inhibitor-resistant mutations on pathogenicity of clade 2.2 A/Turkey/15/06 (H5N1) influenza virus in ferrets. PLoS Pathog. 6:e1000933. doi:10.1371/journal.ppat.1000933.
12. Isoda N, et al. 2006. Pathogenicity of a highly pathogenic avian influenza virus, A/chicken/Yamaguchi/7/04 (H5N1) in different species of birds and mammals. Arch. Virol. 151:1267-1279.
13. Järhult JD, et al. 2011. Environmental levels of the antiviral oseltamivir induce development of resistance mutation H274Y in influenza A/H1N1 virus in mallards. PLoS One 6:e24742. doi:10.1371/journal.pone.0024742.
14. Jo D, Liu D, Yao S, Collins RD, Hawiger J. 2005. Intracellular protein therapy with SOCS inhibits inflammation and apoptosis. Nat. Med. 11: 892-898.
15. Korteweg C, Gu J. 2008. Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans. Am. J. Pathol. 172: 1155-1170.
16. Kuchipudi SV, et al. 2012. Rapid death of duck cells infected with influenza: a potential mechanism for host resistance to H5N1. Immunol. Cell Biol. 90:116-123.
17. Kuchipudi SV, et al. 2009. Differences in influenza virus receptors in chickens and ducks: implications for interspecies transmission. J. Mol. Genet. Med. 3:143-151.
18. La Gruta NL, Kedzierska K, Stambas J, Doherty PC. 2007. A question of self-preservation: immunopathology in influenza virus infection. Immunol. Cell Biol. 85:85-92.
19. Lipatov AS, et al. 2008. Domestic pigs have low susceptibility to H5N1 highly pathogenic avian influenza viruses. PLoS Pathog. 4:e1000102. doi: 10.1371/journal.ppat.1000102.
20. Löndt BZ, et al. 2009. The effect of age on the pathogenesis of a highly pathogenic avian influenza (HPAI) H5N1 virus in Pekin (anas platyrhynchos) ducks infected experimentally. Influenza Other Respi. Viruses 4:17-25.
21. Löndt BZ, et al. 2008. Pathogenesis of highly pathogenic avian influenza A/turkey/Turkey/1/2005 H5N1 in Pekin ducks (Ana platyrhynchos) infected experimentally. Avian Pathol. 37:619-627.
22. Ludwig S. 2009. Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapy. J. Antimicrob. Chemother. 64:1-4.
23. Mai LQ, Wertheim HFL, Duong TN, van Doorn HR, Hien NT. 2010. A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza. N. Engl. J. Med. 362:86-87.
24. Mazur I, et al. 2007. Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-κB-inhibiting activity. Cell. Microbiol. 9:1683-1694.
25. Nelli RK, et al. 2010. Comparative distribution of human and avian type sialic acid influenza receptors in the pig. BMC Vet. Res. 6:4.
26. Nerome K, Ishida M, Oya A, Oda K. 1982. The possible origin of H1N1 (Hsw1N1) virus in the swine population of Japan and antigenic analysis of the isolates. J. Gen. Virol. 62:171-175.
27. Nidom CA, et al. 2010. Influenza A (H5N1) viruses from pigs, Indonesia. Emerg. Infect. Dis. 16:1515-1523.
28. Palmer DC, Restifo NP. 2009. Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function. Trends Immunol. 30: 592-602.
29. Pauli E-K, et al. 2008. Influenza A virus inhibits type 1 IFN signaling via NF-κB-dependent induction of SOCS-3 expression. PLoS Pathog. 4:e1000196. doi:10.1371/journal.ppat.1000196.
30. Peiris JSM, Cheung CY, Leung CYH, Nicholls JM. 2009. Innate immune responses to influenza A H5N1: friend or foe. Trends Immunol. 30:574-584.
31. Perrone LA, Szretter KJ, Katz JM, Mizgerd JP, Tumpey TM. 2010. Mice lacking both TNF and IL-1 receptors exhibit reduced inflammation and delay in onset of death following infection with a highly virulent H5N1 virus. J. Infect. Dis. 202:1161-1170.
32. Pothlichet J, Chignard M, Si-Tahar M. 2008. Innate immune response triggered by influenza A virus is negatively regulated by SOCS1 and SOCS3 through a RIG-I/IFNAR1-dependent pathway. J. Immunol. 180: 2034-2038.
33. Salomon R, Hoffmann E, Webster RG. 2007. Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection. Proc. Natl. Acad. Sci. U. S. A. 104:12479-12481.
34. Shinya K, et al. 2011. Toll-like receptor pre-stimulation protects mice against lethal infection with highly pathogenic influenza viruses. Virol. J. 8:97.
35. Shouda T, et al. 2001. Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis. J. Clin. Invest. 108:1781-1788.
36. Slomka MJ, et al. 2009. Validated RealTime reverse transcriptase PCR methods for the diagnosis and pathotyping of Eurasian H7 avian influenza viruses. Influenza Other Respi. Viruses 3:151-164.
37. Spackman ED, et al. 2002. Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. J. Clin. Microbiol. 40:3256-3260.
38. Svitek N, Rudd PA, Obojes K, Pillet S, von Messling V. 2008. Severe seasonal influenza in ferrets correlates with reduced interferon and increased IL-6 induction. Virology 376:53-59.
39. Szretter KJ, et al. 2007. Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J. Virol. 81:2736-2744.
40. Teijaro JR, et al. 2011. Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell 146:980-991.
41. Thitithanyanont A, et al. 2010. Antiviral immune responses in H5N1-infected human lung tissue and possible mechanisms underlying the hyperproduction of interferon-inducible protein IP-10. Biochem. Biophys. Res. Commun. 398:752-758.
42. Wang H, Ma S. 2008. The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome. Am. J. Emerg. Med. 26:711-715.
43. Wareing MD, Tannock GA. 2008. The induction of proinflammatory cytokines in response to avian influenza H5N1 infections and their role in pathogenesis and enhancement of virulence. Antiinflamm. Antiallergy Agents Med. Chem. 7:71-80.
44. Yoshimura A. 2009. Regulation of cytokine signaling by the SOCS and Spred family proteins. Keio J. Med. 58:73-83.
45. Zakstelskaja LJ, et al. 1978. Influenza in the USSR in 1977: recurrence of influenza virus A subtype H1N1. Bull. World Health Organ. 56:919-922.
46. Zeng H, et al. 2012. Human pulmonary microvascular endothelial cells support productive replication of highly pathogenic avian influenza viruses: possible involvement in the pathogenesis of human H5N1 virus infection. J. Virol. 86:667-678.